Stanley Crooke
Directeur Général chez n-Lorem Foundation
Profil
Stanley T. Crooke a fondé Ionis Pharmaceuticals, Inc. Actuellement, le Dr Crooke est président exécutif de cette société. Il est également membre du conseil d'administration de la Biotechnology Innovation Organization. Il a précédemment occupé le poste de président de la recherche et du développement chez Smithkline Beckman Corp, de président de la recherche et du développement chez Smithkline & French Laboratories US, Inc. et de professeur à l'université d'État de San Diego, au Baylor College of Medicine et à la Perelman School of Medicine. Stanley T. Crooke a obtenu un diplôme d'études supérieures et un doctorat du Baylor College of Medicine et un diplôme de premier cycle de l'université Butler.
Postes actifs de Stanley Crooke
| Sociétés | Poste | Début |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Directeur/Membre du Conseil | - |
| n-Lorem Foundation | Directeur Général | - |
Anciens postes connus de Stanley Crooke
| Sociétés | Poste | Fin |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Directeur Général | 01/01/2020 |
| AKCEA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 08/10/2018 |
| REGULUS THERAPEUTICS INC. | Directeur/Membre du Conseil | 05/11/2012 |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Directeur/Membre du Conseil | 01/01/2006 |
Smithkline Beckman Corp
 Smithkline Beckman Corp Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Smithkline Beckman Corp is a company that manufactures pharmaceutical products. The company is based in Philadelphia, PA. Smithkline Beckman was acquired by Smithkline Beecham Plc on July 27, 1989 for $16,082.37 million. | Directeur Technique/Scientifique/R&D | 01/01/1989 |
Formation de Stanley Crooke
| Baylor College of Medicine | Doctorate Degree |
| Butler University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| REGULUS THERAPEUTICS INC. | Health Technology |
| PERCHERON THERAPEUTICS LIMITED | Health Technology |
| Entreprise privées | 7 |
|---|---|
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
Symphony Genisis, Inc.
 Symphony Genisis, Inc. Pharmaceuticals: MajorHealth Technology Symphony GenIsis, Inc. manufactures biopharmaceutical drugs. It develops and researches on cholesterol-lowering drug, ISIS 301012 and two novel diabetes drugs from its metabolic diseases program. The company is located in Rockville, MD | Health Technology |
Smithkline Beckman Corp
Smithkline Beckman Corp Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Smithkline Beckman Corp is a company that manufactures pharmaceutical products. The company is based in Philadelphia, PA. Smithkline Beckman was acquired by Smithkline Beecham Plc on July 27, 1989 for $16,082.37 million. | Health Technology |
| Smithkline & French Laboratories US, Inc. | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Akcea Therapeutics, Inc.
 Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA. | Health Technology |
| n-Lorem Foundation |
